All Posts: News Release
-
Undergraduate Student Mentored in Georgetown Lombardi Lab Wins Goldwater Scholarship
WASHINGTON — A Georgetown University undergraduate student conducting research on one of the most common and devastating childhood brain tumors has received a prestigious Goldwater Scholarship.
Category: News Release
-
Mindfulness: Is There a Down Side?
WASHINGTON — Mindfulness — that quality of being aware and “in the moment” — is known to increase emotional wellbeing and improve focus. But the benefits of such “explicit” thought do not appear to extend to all cognitive functioning, say researchers at Georgetown University.
Category: News Release
-
Georgetown Bioethicist to Advise Pontifical Council
WASHINGTON — Kevin FitzGerald, PhD, SJ, a Jesuit priest, Georgetown bioethicist and cancer researcher, has been appointed by Pope Francis to serve as a consultor to the Pontifical Council for Culture.
Category: News Release
-
A Single Gene Separates Aggressive and Non-aggressive Lymphatic System Cancer
WASHINGTON — For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn’t require extensive therapy.
Category: News Release
-
Georgetown Huntington Disease Center Studies New Drug to Control Unwanted Movements
WASHINGTON – The Huntington Disease Care, Education and Research Center at MedStar Georgetown University Hospital, in collaboration with Georgetown University Medical Center, is studying a new therapy to manage uncontrollable movements, called chorea, experienced by patients with Huntington disease.
Category: News Release
-
Majority of Older Breast Cancer Patients Use Hormone Treatment
WASHINGTON — One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their oncologists’ recommendations to treat their estrogen-positive breast cancer with hormone therapy — either an aromatase inhibitor or tamoxifen. These drugs prevent tumors from using estrogen to fuel growth.
Category: News Release
-
Tamoxifen Resistant Breast Cancer Reversed When Drug Paired with Anti-malaria Agent
WASHINGTON — The inexpensive anti-malarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen, a widely used breast cancer drug, in mice.
Category: News Release
-
Media Advisory: The Men’s Event Benefitting Prostate Cancer Research
Last year, nearly 239,000 men were diagnosed with prostate cancer, and according to the American Cancer Society, about 30,000 men died from the disease. On Monday, June 23, for the 15th year, prominent Washington, DC-area businessmen will gather for The Men’s Event to support prostate cancer research happening at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Georgetown Starts Study to Halt Alzheimer’s Disease in Those at High-Risk
WASHINGTON–Georgetown University Medical Center researchers have launched a clinical study aimed at preventing or delaying Alzheimer’s disease in people who don’t have symptoms but already have the tale-tell signs in their brains.
Category: News Release
-
Resistance to Lung Cancer Targeted Therapy Can be Reversed, Study Suggests
WASHINGTON — Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth — a puzzling clinical setback that researchers have long tried to solve. Now, scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why that intrinsic resistance occurs — and they pinpoint a drug they say could potentially reverse it.
Category: News Release